Exploring 3-Methoxyamphetamine. To explore a different substance…

Names:
3-MA · MMA · 3-MeO-AMP · 3-Methoxyamphetamine
IUPAC name:
1-(3-Methoxyphenyl)propan-2-amine
ID: 268 · Formula: C10H15NO · Molecular weight: 165.232
InChI: InChI=1S/C10H15NO/c1-8(11)6-9-4-3-5-10(7-9)12-2/h3-5,7-8H,6,11H2,1-2H3

Segawa, H; Iwata, YT; Yamamuro, T; Kuwayama, K; Tsujikawa, K; Kanamori, T; Inoue, H. Differentiation of ring-substituted regioisomers of amphetamine and methamphetamine by supercritical fluid chromatography: Differentiation of ring-substituted regioisomers by supercritical fluid chromatography. Drug Test. Analysis, 1 Jan 2016, 9 (3), 389-398. 1.3 MB. http://dx.doi.org/10.1002/dta.2040

Warren, RJ; Begosh, PP; Zarembo, JE. Identification of amphetamines and related sympathomimetic amines. J. Assoc. Off. Anal. Chem., 1971, 54 (5), 1179–1191. 3.9 MB.

Foster, BC; Litster, DL; Lodge, BA. Biotransformation of 2-, 3-, and 4-methoxyamphetamines by Cunninghamella echinulata. Xenobiotica, 1991, 21 (10), 1337–1346. 553 kB. http://dx.doi.org/10.3109/00498259109043208

Katagi, M; Tsuchihashi, H. Update on clandestine amphetamines and their analogues recently seen in Japan. J. Health Sci., 2002, 48 (1), 14–21. 181 kB. http://dx.doi.org/10.1248/jhs.48.14

Glennon, RA; Liebowitz, SM; Anderson, GM. Serotonin receptor affinities of psychoactive phenalkylamine analogues. J. Med. Chem., 1 Mar 1980, 23 (3), 294–299. 844 kB. http://dx.doi.org/10.1021/jm00177a017

Glennon, RA; McKenney, JD; Lyon, RA; Titeler, M. 5-HT1 and 5-HT2 binding characteristics of 1-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane analogs. J. Med. Chem., 1 Feb 1986, 29 (2), 194–199. 919 kB. http://dx.doi.org/10.1021/jm00152a005

Domelsmith, LN; Eaton, TA; Houk, KN; Anderson, GM; Glennon, RA; Shulgin, AT; Castagnoli, N; Kollman, PA. Photoelectron spectra of psychotropic drugs. 6. Relationships between physical properties and pharmacological actions of amphetamine analogues. J. Med. Chem., 1 Jan 1981, 24 (12), 1414–1421. 963 kB. http://dx.doi.org/10.1021/jm00144a009

Dal Cason, TA. A re-examination of the mono-methoxy positional ring isomers of amphetamine, methamphetamine and phenyl-2-propanone. Forensic Sci. Int., 1 Jan 2001, 119 (3), 168–194. 678 kB. http://dx.doi.org/10.1016/S0379-0738(00)00425-4

Nakanishi, K; Miki, A; Zaitsu, K; Kamata, H; Shima, N; Kamata, T; Katagi, M; Tatsuno, M; Tsuchihashi, H; Suzuki, K. Cross-reactivities of various phenethylamine-type designer drugs to immunoassays for amphetamines, with special attention to the evaluation of the one-step urine drug test Instant-View™, and the Emit® assays for use in drug enforcement. Forensic Sci. Int., 10 Apr 2012, 217 (1–3), 174–181. 397 kB. http://dx.doi.org/10.1016/j.forsciint.2011.11.003

Glennon, RA. Bath salts, mephedrone, and methylenedioxypyrovalerone as emerging illicit drugs that will need targeted therapeutic intervention. Advances in Pharmacology, 2014, 69, 581–620. 564 kB. http://dx.doi.org/10.1016/B978-0-12-420118-7.00015-9

Lyon, RA; Titeler, M; Seggel, MR; Glennon, RA. Indolealkylamine analogs share 5-HT2 binding characteristics with phenylalkylamine hallucinogens. Eur. J. Pharmacol., 19 Jan 1988, 145 (3), 291–297. 533 kB. http://dx.doi.org/10.1016/0014-2999(88)90432-3

Glennon, RA; Rosecrans, JA; Young, R. Behavioral properties of psychoactive phenylisopropylamines in rats. Eur. J. Pharmacol., 17 Dec 1981, 76 (4), 353–360. 964 kB. http://dx.doi.org/10.1016/0014-2999(81)90106-0

Antun, F; Smythies, JR; Benington, F; Morin, RD; Barfknecht, CF; Nichols, DE. Native fluorescence and hallucinogenic potency of some amphetamines. Experientia, 15 Jan 1971, 27 (1), 62–63. 248 kB. http://dx.doi.org/10.1007/BF02137743

Bailey, K; Legault, D. 13C NMR spectra and structure of mono-, di- and trimethoxyphenylethylamines and amphetamines. Org. Magn. Resonance, 1 Jun 1983, 21 (6), 391–396. 680 kB. http://dx.doi.org/10.1002/omr.1270210611

Bailey, K; Beckstead, HD; Legault, D; Verner, D. Identification of 2-, 3-, and 4-methoxyamphetamines and 2-, 3-, and 4-methylamphetamines. J. Assoc. Off. Anal. Chem., 1974, 57 (5), 1134–1143. 2.6 MB.

3-MMA · 3-Methoxymethamphetamine
N,N-Me-3-MA
N-Et-3-MA
N,N-Et-3-MA
N-Bu-3-MA
1534
1535
1536
1095
3-MPEA
4C-3-MPEA
BO3MA
BO3MEA
2,3-DMA
PAL-314 · 3-Methylamphetamine
A · Amphetamine
3-FA · 3-Fluoroamphetamine
3-TFMA · Norfenfluramine
3-HA · Gepefrine
3-CA · 3-Chloroamphetamine
3-EA
3-MTA
3-Br-AMP · 3-Bromoamphetamine
3-IA
3,4-DMA
MMA
4-Br-3-MA
2333
4-Cl-3-MA
MHA
3-MTFMA
BZOMA
IPOMA
POMA
3,5-DMA
5-PhPr-2-MA
7-MAT
3-MeOPP
2464
2,3-DMBZP · 3,4-DMBZP
PMA
2-MA · 2-Methoxyamphetamine
Ephedrine
Pseudoephedrine
Hordenine
β-Methoxyamphetamine
4-Methylnorephedrine
β-HO-N,N-Me-PEA
N,N-Me-2-HPEA
2-HMA
N-Me-2-MPEA
β-Me-2-MPEA
N,N-Me-3-HPEA
N-Me-3-MPEA
β-Me-3-MPEA
4-HMA · Pholedrine
α-Et-4-HPEA
N-Me-4-MPEA
β-Me-4-MPEA
4-EPEA
2,3-HMeMPEA
2,3-HMeA
2,4-MMPEA
β-HO-3,4-MePEA
Phenylpropanolmethylamine
N-MeO-A
4-Me-HOT-A
3-MMA · 3-Methoxymethamphetamine
N,N-Me-3-MA
N-Et-3-MA
N,N-Et-3-MA
N-Bu-3-MA
1534
1535
1536
1095
3-MPEA
4C-3-MPEA
BO3MA
BO3MEA
2,3-DMA
PAL-314 · 3-Methylamphetamine
A · Amphetamine
3-FA · 3-Fluoroamphetamine
3-TFMA · Norfenfluramine
3-HA · Gepefrine
3-CA · 3-Chloroamphetamine
3-EA
3-MTA
3-Br-AMP · 3-Bromoamphetamine
3-IA
3,4-DMA
MMA
4-Br-3-MA
2333
4-Cl-3-MA
MHA
3-MTFMA
BZOMA
IPOMA
POMA
3,5-DMA
5-PhPr-2-MA
7-MAT
3-MeOPP
2464
2,3-DMBZP · 3,4-DMBZP
PMA
2-MA · 2-Methoxyamphetamine
Ephedrine
Pseudoephedrine
Hordenine
β-Methoxyamphetamine
4-Methylnorephedrine
β-HO-N,N-Me-PEA
N,N-Me-2-HPEA
2-HMA
N-Me-2-MPEA
β-Me-2-MPEA
N,N-Me-3-HPEA
N-Me-3-MPEA
β-Me-3-MPEA
4-HMA · Pholedrine
α-Et-4-HPEA
N-Me-4-MPEA
β-Me-4-MPEA
4-EPEA
2,3-HMeMPEA
2,3-HMeA
2,4-MMPEA
β-HO-3,4-MePEA
Phenylpropanolmethylamine
N-MeO-A
4-Me-HOT-A
19 November 2017 · Creative Commons BY-NC-SA ·